April 29, 2022 Where We Are Now on the COVID-19 TRIPS Proposal—Is an IP Waiver the Right Way to Address Vaccine Inequity? By Kelsey Price
April 11, 2022 Mathematical Scrutiny: Genus Claims and Enablement Analysis at the Federal Circuit By Tasos Kanopoulos
February 28, 2022 The Meatless Monopoly: Plant-Based Companies Using IP Protections to Expand their Brands By Katharine Keane
December 11, 2021 Patent Subject Matter Eligibility in the Biotechnology Industry By Mikaella Evaristo
December 11, 2021 Can Moral Utility Deter American Tech’s Complicity in Human Rights Abuses? By Kevin Ruane
December 11, 2021 Are Digital Inventors Real? Issues with Artificial Intelligence and Patent Invention By Odeya de la Mure